Cardiovascular Systems Inc (CSII):製品パイプライン分析

【英語タイトル】Cardiovascular Systems Inc (CSII) - Product Pipeline Analysis, 2017 Update

GlobalDataが出版した調査資料(DATA8010070)・商品コード:DATA8010070
・発行会社(調査会社):GlobalData
・発行日:2017年12月27日
・ページ数:32
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥169,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥254,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for treating peripheral and coronary vascular disease. The company offers products such as peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accessories. Its PAD system is a percutaneous orbital atherectomy system that is used as therapy for occlusive atherosclerotic disease in peripheralarteries and stenotic material from artificial arteriovenous dialysis fistulae. CSI offers accessories such as guide wire, lubricant, pump and tape. The company serves patients suffering from peripheral arterial disease and coronary artery diseases. It markets its products through its network of distributors. CSI is headquartered in St. Paul, Minnesota, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Cardiovascular Systems Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Cardiovascular Systems Inc Company Overview 4
Cardiovascular Systems Inc Company Snapshot 4
Cardiovascular Systems Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Cardiovascular Systems Inc – Pipeline Analysis Overview 7
Cardiovascular Systems Inc – Key Facts 7
Cardiovascular Systems Inc – Major Products and Services 8
Cardiovascular Systems Inc Pipeline Products by Development Stage 9
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status 11
Cardiovascular Systems Inc Pipeline Products Overview 13
Diamondback 360 Coronary OAS Micro Crown 13
Diamondback 360 Coronary OAS Micro Crown Product Overview 13
Diamondback 360 Coronary Orbital Atherectomy System 14
Diamondback 360 Coronary Orbital Atherectomy System Product Overview 14
Diamondback 360 Coronary Orbital Atherectomy System Clinical Trial 15
Diamondback 360 Peripheral Orbital Atherectomy System 16
Diamondback 360 Peripheral Orbital Atherectomy System Product Overview 16
Diamondback 360 Peripheral Orbital Atherectomy System Clinical Trial 17
Cardiovascular Systems Inc – Key Competitors 18
Cardiovascular Systems Inc – Key Employees 19
Cardiovascular Systems Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Cardiovascular Systems Inc, Recent Developments 21
Oct 25, 2017: Cardiovascular Systems Reports Fiscal 2018 First-Quarter Financial Results 21
Sep 18, 2017: Cardiovascular Systems Announces Anticipated Revenue Impact from Hurricanes Harvey and Irma 22
Sep 11, 2017: Lesion Preparation Using Diamondback 360 Orbital Atherectomy System Enhances Paclitaxel Distribution in Calcified Peripheral Arteries 22
Aug 10, 2017: LIBERTY 360° Study 12-Month Data Demonstrate Lasting Benefits Following Endovascular Intervention in Patients with Critical Limb Ischemia 23
Aug 10, 2017: LIBERTY 360° Study 12-Month Sub-Analysis Reveals High Freedom from Major Amputation and Major Adverse Events (MAE) Using Cardiovascular Systems’ Diamondback 360 Peripheral Orbital Atherectomy System (OAS) 24
Aug 02, 2017: Cardiovascular Systems Reports Fiscal 2017 Fourth-Quarter Financial Results 24
May 04, 2017: FDA Approves Cardiovascular Systems’ Replacement Saline Infusion Pump 26
May 03, 2017: Cardiovascular Systems Reports Fiscal 2017 Third-Quarter Financial Results 26
Apr 17, 2017: Cardiovascular Systems Initiates Voluntary Recall of Saline Infusion Pump 27
Mar 30, 2017: Cardiovascular Systems Receives Approval for the Diamondback 360 Coronary Orbital Atherectomy System Micro Crown in the United States 28
Appendix 29
Methodology 29
About GlobalData 31
Contact Us 31
Disclaimer 32

List of Tables
Cardiovascular Systems Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Cardiovascular Systems Inc Pipeline Products by Equipment Type 5
Cardiovascular Systems Inc Pipeline Products by Indication 6
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status 6
Cardiovascular Systems Inc, Key Facts 7
Cardiovascular Systems Inc, Major Products and Services 8
Cardiovascular Systems Inc Number of Pipeline Products by Development Stage 9
Cardiovascular Systems Inc Pipeline Products Summary by Development Stage 10
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status 11
Cardiovascular Systems Inc Ongoing Clinical Trials Summary 12
Diamondback 360 Coronary OAS Micro Crown - Product Status 13
Diamondback 360 Coronary OAS Micro Crown - Product Description 13
Diamondback 360 Coronary Orbital Atherectomy System - Product Status 14
Diamondback 360 Coronary Orbital Atherectomy System - Product Description 14
Diamondback 360 Coronary Orbital Atherectomy System - Comparison of Orbital Versus Rotational Atherectomy Effects on Coronary Microcirculation in Percutaneous Coronary Intervention (PCI) 15
Diamondback 360 Coronary Orbital Atherectomy System - Evaluation of Treatment Strategies for Severe CalcIfic Coronary Arteries: Orbital Atherectomy versus Conventional Angioplasty Technique Prior to Implantation of Drug-eluting Stents: The ECLIPSE Trial 15
Diamondback 360 Peripheral Orbital Atherectomy System - Product Status 16
Diamondback 360 Peripheral Orbital Atherectomy System - Product Description 16
Diamondback 360 Peripheral Orbital Atherectomy System - Orbital Vessel Preparation to Maximize DCB Efficacy in Calcified below the Knee (BTK) Lesions - A Pilot Study 17
Diamondback 360 Peripheral Orbital Atherectomy System - Prospective, Observational, Multi-center Clinical Study to Evaluate Acute and Long Term Clinical and Economic Outcomes of Endovascular Device Intervention in Patients with Distal Outflow Peripheral Arterial Disease (PAD): LIBERTY 360 17
Cardiovascular Systems Inc, Key Employees 19
Glossary 30

★調査レポート[Cardiovascular Systems Inc (CSII):製品パイプライン分析] (コード:DATA8010070)販売に関する免責事項を必ずご確認ください。
★調査レポート[Cardiovascular Systems Inc (CSII):製品パイプライン分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆